281 related articles for article (PubMed ID: 33824379)
1. Plasma microrna expression profile for reduced ejection fraction in dilated cardiomyopathy.
Calderon-Dominguez M; Belmonte T; Quezada-Feijoo M; Ramos M; Calderon-Dominguez J; Campuzano O; Mangas A; Toro R
Sci Rep; 2021 Apr; 11(1):7517. PubMed ID: 33824379
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of circulating miRNAs as a novel tool to assess BAG3-associated familial dilated cardiomyopathy.
Zaragoza C; Saura M; Hernández I; Ramirez-Carracedo R; García-García F; Zamorano JL; Mangas A; Toro R
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30792263
[TBL] [Abstract][Full Text] [Related]
3. Plasma microRNAs as biomarkers for Lamin A/C-related dilated cardiomyopathy.
Toro R; Blasco-Turrión S; Morales-Ponce FJ; Gonzalez P; Martínez-Camblor P; López-Granados A; Brugada R; Campuzano O; Pérez-Serra A; Rosa Longobardo F; Mangas A; Llorente-Cortes V; de Gonzalo-Calvo D
J Mol Med (Berl); 2018 Aug; 96(8):845-856. PubMed ID: 30008018
[TBL] [Abstract][Full Text] [Related]
4. MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM.
Li M; Chen X; Chen L; Chen K; Zhou J; Song J
J Transl Med; 2018 Jun; 16(1):161. PubMed ID: 29885652
[TBL] [Abstract][Full Text] [Related]
5. Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach.
Becker S; Florian A; Patrascu A; Rösch S; Waltenberger J; Sechtem U; Schwab M; Schaeffeler E; Yilmaz A
J Cardiovasc Magn Reson; 2016 May; 18(1):25. PubMed ID: 27150296
[TBL] [Abstract][Full Text] [Related]
6. Right ventricular morphology and function is not related with microRNAs and fibrosis markers in dilated cardiomyopathy.
Rubiś P; Totoń-Żurańska J; Wiśniowska-Śmiałek S; Kołton-Wróż M; Wołkow P; Wypasek E; Rudnicka-Sosin L; Pawlak A; Kozanecki K; Tomkiewicz-Pająk L; Podolec P
Cardiol J; 2018; 25(6):722-731. PubMed ID: 28840590
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNAs as novel biomarkers for dilated cardiomyopathy.
Wang H; Chen F; Tong J; Li Y; Cai J; Wang Y; Li P; Hao Y; Tian W; Lv Y; Chong J; Yang J
Cardiol J; 2017; 24(1):65-73. PubMed ID: 27748501
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNA as a biomarker for recovery in pediatric dilated cardiomyopathy.
Miyamoto SD; Karimpour-Fard A; Peterson V; Auerbach SR; Stenmark KR; Stauffer BL; Sucharov CC
J Heart Lung Transplant; 2015 May; 34(5):724-33. PubMed ID: 25840506
[TBL] [Abstract][Full Text] [Related]
9. Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy.
Fan KL; Zhang HF; Shen J; Zhang Q; Li XL
Indian Heart J; 2013; 65(1):12-6. PubMed ID: 23438607
[TBL] [Abstract][Full Text] [Related]
10. Serum Exosomal MiR-92b-5p as a Potential Biomarker for Acute Heart Failure Caused by Dilated Cardiomyopathy.
Wu T; Chen Y; Du Y; Tao J; Zhou Z; Yang Z
Cell Physiol Biochem; 2018; 46(5):1939-1950. PubMed ID: 29719295
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNA-29-5p can add to the discrimination between dilated cardiomyopathy and ischaemic heart disease.
Brundin M; Wågsäter D; Alehagen U; Carlhäll CJ
ESC Heart Fail; 2021 Oct; 8(5):3865-3874. PubMed ID: 34173728
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional echocardiographic comparison of left ventricular geometry and systolic function between dilated cardiomyopathy and mitral regurgitation with similar left ventricular dilation.
Zeng D; Wu J; Wu SS; Lin HH; Chen H
J Clin Ultrasound; 2020 Jan; 48(1):29-37. PubMed ID: 31566758
[TBL] [Abstract][Full Text] [Related]
13. Circulating miR-185 might be a novel biomarker for clinical outcome in patients with dilated cardiomyopathy.
Yu M; Liang W; Xie Y; Long Q; Cheng X; Liao YH; Yuan J
Sci Rep; 2016 Sep; 6():33580. PubMed ID: 27645404
[TBL] [Abstract][Full Text] [Related]
14. Relations between circulating and myocardial fibrosis-linked microRNAs with left ventricular reverse remodeling in dilated cardiomyopathy.
Dziewięcka E; Totoń-Żurańska J; Wołkow P; Kołton-Wróż M; Pitera E; Wiśniowska-Śmiałek S; Khachatryan L; Karabinowska A; Szymonowicz M; Podolec P; Rubiś P
Adv Clin Exp Med; 2020 Mar; 29(3):285-293. PubMed ID: 32207584
[TBL] [Abstract][Full Text] [Related]
15. The relationship between myocardial fibrosis and myocardial microRNAs in dilated cardiomyopathy: A link between mir-133a and cardiovascular events.
Rubiś P; Totoń-Żurańska J; Wiśniowska-Śmiałek S; Dziewięcka E; Kołton-Wróż M; Wołkow P; Pitera E; Rudnicka-Sosin L; Garlitski AC; Gackowski A; Podolec P
J Cell Mol Med; 2018 Apr; 22(4):2514-2517. PubMed ID: 29377565
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular reverse remodeling in dilated cardiomyopathy- maintained subclinical myocardial systolic and diastolic dysfunction.
Amorim S; Rodrigues J; Campelo M; Moura B; Martins E; Macedo F; Silva-Cardoso J; Maciel MJ
Int J Cardiovasc Imaging; 2017 May; 33(5):605-613. PubMed ID: 28013418
[TBL] [Abstract][Full Text] [Related]
17. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of miR-208b improves cardiac function in titin-based dilated cardiomyopathy.
Zhou Q; Schötterl S; Backes D; Brunner E; Hahn JK; Ionesi E; Aidery P; Sticht C; Labeit S; Kandolf R; Gawaz M; Gramlich M
Int J Cardiol; 2017 Mar; 230():634-641. PubMed ID: 28065693
[TBL] [Abstract][Full Text] [Related]
19. Plasma microRNA profiling of children with idiopathic dilated cardiomyopathy.
Enes Coşkun M; Kervancıoğlu M; Öztuzcu S; Yılmaz Coşkun F; Ergün S; Başpınar O; Kılınç M; Temel L; Coşkun MY
Biomarkers; 2016; 21(1):56-61. PubMed ID: 26631154
[TBL] [Abstract][Full Text] [Related]
20. Analysis of left ventricular fluid dynamics in dilated cardiomyopathy by echocardiographic particle image velocimetry.
Tang C; Zhu Y; Zhang J; Niu C; Liu D; Liao Y; Zhu L; Peng Q
Echocardiography; 2018 Jan; 35(1):56-63. PubMed ID: 29082600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
